News

Cancer Insight Is Now LumaBridge

August 23, 2022  |  San Antonio, TX
Cancer Insight today introduced a new corporate identity: LumaBridge. As LumaBridge, the company will continue to build on its legacy of supporting the development of novel immunotherapies in the fight against cancer.

Read More